{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:36:22Z","timestamp":1785245782272,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["P3-0296"],"award-info":[{"award-number":["P3-0296"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.diagmicrobio.2018.01.025","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:35:18Z","timestamp":1517560518000},"page":"156-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Is the risk of early neurologic Lyme borreliosis reduced by preferentially treating patients with erythema migrans with doxycycline?"],"prefix":"10.1016","volume":"91","author":[{"given":"Franc","family":"Strle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da\u0161a","family":"Stupica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bogovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Visintainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Wormser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0005","first-page":"485","article-title":"Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth)","volume":"57","author":"Ackermann","year":"1984","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0010","first-page":"524","article-title":"Children with multiple erythema migrans: are there any pre-treatment symptoms and\/or signs suggestive for central nervous system involvement?","volume":"114","author":"Arnez","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0015","first-page":"498","article-title":"Comparison of azithromycin and phenoxymethylpenicillin for treatment of children with solitary erythema migrans","volume":"114","author":"Arnez","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0020","first-page":"916","article-title":"Comparison of cefuroxime axetil and phenoxymethlypenicillin for treatment of children with solitary erythema migrans","volume":"111","author":"Arnez","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/INF.0000000000000804","article-title":"Azithromycin is equally effective as amoxicillin in children with solitary erythema migrans","volume":"34","author":"Arnez","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s150100050069","article-title":"Comparison of azithromycin and doxycycline in the treatment of erythema migrans","volume":"28","author":"Barsic","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0035","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0050","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/0140-6736(90)93103-V","article-title":"Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis","volume":"2","author":"Dattwyler","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0055","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1542\/peds.109.6.1173","article-title":"Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease","volume":"109","author":"Eppes","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02527737","article-title":"Pain syndromes in tick-borne neuroborreliosis. Clinical aspects and differential diagnosis","volume":"1","author":"Kohler","year":"1987","journal-title":"Schmerz"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0065","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial","volume":"7","author":"Lj\u00f8stad","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","article-title":"Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial","volume":"124","author":"Luft","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0075","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jama.1992.03480100070033","article-title":"Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection","volume":"267","author":"Luft","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/AAC.39.3.661","article-title":"Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans","volume":"39","author":"Luger","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90270-L","article-title":"Treatment of early Lyme disease","volume":"92","author":"Massarotti","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease","volume":"117","author":"Nadelman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00508-012-0194-1","article-title":"Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin","volume":"124","author":"Nizic","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early European Lyme neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0110","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01780661","article-title":"Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans","volume":"24","author":"Strle","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01710737","article-title":"Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings","volume":"21","author":"Strle","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/30.4.543","article-title":"Erythema migrans: comparison of treatment with azithromycin, doxycycline, and phenoxymethyl penicillin","volume":"30","author":"Strle","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb8130","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkx534","article-title":"Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial","author":"Stupica","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01728915","article-title":"Azithromycin versus penicillin for the treatment of early Lyme borreliosis","volume":"21","author":"Weber","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0140","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/323424","article-title":"Yield of large-volume blood cultures in patients with early Lyme disease","volume":"184","author":"Wormser","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0145","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-142-9-200505030-00011","article-title":"Hematogenous dissemination in early Lyme disease","volume":"142","author":"Wormser","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2018.01.025_bb0155","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease: a randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:55:58Z","timestamp":1535115358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318300427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0732889318300427"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.01.025","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the risk of early neurologic Lyme borreliosis reduced by preferentially treating patients with erythema migrans with doxycycline?","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}